|
|
 |
|
Viewing report
|
|
|
|
Company Financials: Array Biopharma Inc.
Datamonitor, Jan 2010
The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet, and cash flow statements. .
Scope
- Contains five years data on income statement, balance sheet, cash flows and other financials in the reported currency and its US Dollar translation
- Provides key ratios
- Includes information on revenue distribution by business segments and geographies
Highlights of this title
Array BioPharma is a biopharmaceutical company engaged in the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer, inflammatory, and metabolic diseases.
Key reasons to purchase this title
- Access important financial information and analysis on the company in a single datapack
- Understand the financial evolution of the company over the last five years
- Build the periodic assessment of the company's performance for five year adjusted financial data along with key ratios and market capitalization
Customers who bought this item also bought
Company Financials: ARCA Biopharma, Inc.
Company Financials: Labopharm Inc.
Company Financials: Bristol-Myers Squibb Company
Company Financials: Eli Lilly and Company
Company Financials: Arqule, Inc.
Company Financials: Biogen Idec, Inc.
Company Financials: Becton, Dickinson and Company
Company Financials: Genzyme Corporation
Company Financials: Hologic, Inc.
Company Financials: Biocryst Pharmaceuticals
|
|
|
|
